华仁药业
(300110)
| 流通市值：31.43亿 | | | 总市值：31.45亿 |
| 流通股本：11.81亿 | | | 总股本：11.82亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 873,969,132.95 | 605,047,701.2 | 309,965,165.17 | 1,321,454,092.38 |
| 营业总成本 | 828,714,628.7 | 561,308,128.71 | 289,559,960.82 | 1,204,460,892.77 |
| 其他经营收益 | | | | |
| 营业利润 | 45,406,583.02 | 39,748,014.83 | 22,906,526.2 | -455,695,265.81 |
| 利润总额 | 43,094,603.7 | 38,943,191.17 | 20,079,295.86 | -458,941,315.8 |
| 净利润 | 29,604,175.45 | 30,410,148.46 | 16,803,409 | -459,389,075.8 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 29,604,175.45 | 30,410,148.46 | 16,803,409 | -459,389,075.8 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,067,748,125.17 | 1,089,529,996.59 | 1,106,070,983.53 | 993,875,817.08 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,642,217,593.17 | 1,660,059,937.99 | 1,681,594,718.89 | 1,708,126,307.09 |
| 资产总计 | 2,709,965,718.34 | 2,749,589,934.58 | 2,787,665,702.42 | 2,702,002,124.17 |
| 流动负债: | | | | |
| 流动负债合计 | 1,257,310,615.4 | 1,361,052,664.84 | 1,348,688,816.4 | 1,474,532,115.45 |
| 非流动负债: | | | | |
| 非流动负债合计 | 517,278,685.43 | 449,066,753.02 | 513,113,108.76 | 318,409,640.46 |
| 负债合计 | 1,774,589,300.83 | 1,810,119,417.86 | 1,861,801,925.16 | 1,792,941,755.91 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 864,800,967.29 | 866,428,683.45 | 853,844,873.11 | 837,886,271.38 |
| 股东权益合计 | 935,376,417.51 | 939,470,516.72 | 925,863,777.26 | 909,060,368.26 |
| 负债和股东权益合计 | 2,709,965,718.34 | 2,749,589,934.58 | 2,787,665,702.42 | 2,702,002,124.17 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 883,260,515.09 | 587,220,957.78 | 262,772,516.21 | 1,395,267,417.71 |
| 经营活动现金流出小计 | 754,944,312.44 | 512,146,512.76 | 248,504,296.32 | 1,005,033,888.48 |
| 经营活动产生的现金流量净额 | 128,316,202.65 | 75,074,445.02 | 14,268,219.89 | 390,233,529.23 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 3,000 | - | - | 2,089,264.91 |
| 投资活动现金流出小计 | 14,060,944.2 | 9,705,041.12 | 4,873,854.02 | 48,980,335.29 |
| 投资活动产生的现金流量净额 | -14,057,944.2 | -9,705,041.12 | -4,873,854.02 | -46,891,070.38 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 707,245,552.09 | 556,054,854.09 | 422,874,854.09 | 628,845,250 |
| 筹资活动现金流出小计 | 735,334,873.43 | 542,923,082.07 | 380,650,854.15 | 1,023,642,502.3 |
| 筹资活动产生的现金流量净额 | -28,089,321.34 | 13,131,772.02 | 42,223,999.94 | -394,797,252.3 |
| 汇率变动对现金及现金等价物的影响 | -4,685.67 | -4,129.68 | -1,322.48 | 4,666.74 |
| 现金及现金等价物净增加额 | 86,164,251.44 | 78,497,046.24 | 51,617,043.33 | -51,450,126.71 |
| 期末现金及现金等价物余额 | 181,513,878.55 | 173,846,673.35 | 146,966,670.44 | 95,349,627.11 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 78,497,046.24 | - | -51,450,126.71 |